Gland Pharma Limited (GLAND.NS)

INR 1764.95

(0.06%)

Total Debt Summary of Gland Pharma Limited

  • Gland Pharma Limited's latest annual total debt in 2023 was 3.72 Billion INR , up 8257.65% from previous year.
  • Gland Pharma Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Gland Pharma Limited reported annual total debt of 44.53 Million INR in 2022, down -6.11% from previous year.
  • Gland Pharma Limited reported annual total debt of 47.43 Million INR in 2021, down -5.05% from previous year.
  • Gland Pharma Limited reported quarterly total debt of 2.94 Billion INR for 2024 Q2, down 0.0% from previous quarter.
  • Gland Pharma Limited reported quarterly total debt of - INR for 2023 Q3, down -100.0% from previous quarter.

Annual Total Debt Chart of Gland Pharma Limited (2023 - 2016)

Historical Annual Total Debt of Gland Pharma Limited (2023 - 2016)

Year Total Debt Total Debt Growth
2023 3.72 Billion INR 8257.65%
2022 44.53 Million INR -6.11%
2021 47.43 Million INR -5.05%
2020 49.95 Million INR -16.9%
2019 60.11 Million INR -9.35%
2018 66.31 Million INR -7.1%
2017 71.38 Million INR 11.95%
2016 63.76 Million INR 0.0%

Peer Total Debt Comparison of Gland Pharma Limited

Name Total Debt Total Debt Difference
Abbott India Limited 832.3 Million INR -347.154%
Cipla Limited 5.59 Billion INR 33.472%
GlaxoSmithKline Pharmaceuticals Limited 186.65 Million INR -1893.924%
Kopran Limited 992.28 Million INR -275.06%
Marksans Pharma Limited 2.44 Billion INR -52.489%
NGL Fine-Chem Limited 324.42 Million INR -1047.159%
Pfizer Limited 945.4 Million INR -293.66%
Sanofi India Limited 190 Million INR -1858.768%
SMS Pharmaceuticals Limited 2.8 Billion INR -32.552%
TTK Healthcare Limited 228.1 Million INR -1531.548%